lentivirus
Streamlining Viral Gene Therapy Development
The Scientist and Charles River Laboratories, Inc. | Aug 27, 2024 | 3 min read
Off-the-shelf and custom plasmid DNA and viral vector products help scientists take their gene therapy research to the next level.
Hijacking Viruses: Optimizing Lentivirus-Based Cell Engineering
The Scientist | Dec 19, 2023 | 1 min read
Filippo Rossignoli discusses the challenges he faced when employing lentiviruses to produce immunotherapies and how he overcame these obstacles.
Viral Vector Platforms for Gene Therapy
The Scientist | Feb 9, 2023 | 1 min read
In both the laboratory and clinic, scientists harness viral genetic transfer capabilities to develop gene therapies that modulate cellular function.
Considerations for Gene Therapy Manufacturing Strategies
Thermo Fisher Scientific | Oct 24, 2022 | 1 min read
Discover tips for setting up and optimizing adeno-associated virus production.
Participant’s Diagnosis Halts Gene Therapy Clinical Trial
Amanda Heidt | Aug 12, 2021 | 3 min read
The FDA pauses the research program on a lentivirus-based treatment for a rare neurological condition after a patient developed a bone marrow disorder that could presage leukemia.